The MedicineMatters website (a resource for healthcare professionals) is offering a 13-minute video of a discussion between Prof David Jayne of Cambridge University and Prof Sebastian E. Sattui of theUniversity …
Melody Study (updated)
UPDATE 6 Feb 2022: We have good news – the invitations to the MELODY study (Mass evaluation of lateral flow immunoassays (at home finger prick antibody tests) for the detection of …
Survey – impact of steroids
Are you being treated with steroids for your rheumatic condition? We need your help to test a new questionnaire about steroid impact on quality of life for people living in …
UKIVAS Vasculitis Webinar
The Second UKIVAS Online Educational Vasculitis Webinar for Medical Professionals Over two days, November 17th and 18th 2021, UKIVAS, the UK & Ireland Vasculitis Study Group, teamed up in partnership with the Royal …
New Research Study
Would you like to help with a research study to better understand why some people with inflammatory conditions affecting the joints or the gut, and treated with immune suppressing medications …
Covid Vaccine – Booster Doses/Third Vaccine Explained
BOOSTER DOSE The effectiveness of vaccines tends to wear off with time, especially in older or very young people. The Booster dose is for those who have had both doses …
Mirror interview for Hannah
‘Wonder drug keeps me alive – but I may never be protected against Covid’ – Mirror Online Vasculitis patient Hannah Burden has secured valuable media coverage to help the public …
Covid – Third Jab
The JCVI is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule. The third dose, which is …
Third vaccine dose: trial
A new clinical trial will investigate whether a third dose of vaccine for people with weakened immune systems gives a stronger immune response than two doses. The £2.2 million study …
OCTAVE study – initial findings
OCTAVE study initial findings reveal vaccine responses in patients with impaired immune systems Published 24th August 2021 These findings are particularly concerning for those treated with rituximab with the highest proportion of …